|Home||» Products||» Biosimilar injection|
Prescribed for treating diseases like chronic hepatitis C, hemostasis, deficiency of congenital fibrinogen and chronic hepatitis C, the offered Biosimilar Injection is preferred for its precise formulation and side effect free content. The offered injection is also prescribed to treat bleeding from small venules and capillaries. The advanced composition of this injection prevents clotting of blood by activating special substances present in human body as blood clotting may lead to heart attack. The erythroprotein present in Biosimilar Injection accelerates red blood cell generation.